scholarly journals IMMUNOLOGICAL PREDICTORS OF RENAL GRAFT REJECTION IN THE EARLY POSTOPERATIVE PERIOD

2021 ◽  
Vol 29 (3) ◽  
pp. 311-317
Author(s):  
S.V. Zybleva ◽  
◽  
S.L. Zyblev ◽  

Objective. To determine the immunological predictors of renal graft rejection in the early postoperative period. Methods. Three groups were formed out of the 197 renal graft recipients. The group PGF (n=101) was made up of patients with satisfactory primary graft function. The group PGD (n = 82) included patients with primary graft dysfunction without episodes of rejection. The group RGR (n=14) consisted of patients with primary dysfunction and renal graft rejection. On the 7<sup>th</sup> day after transplantation the early kidney graft function was assessed on the basis ofserum creatinine levels. When the serum creatinine value was lower than 300 μmol/L the function was considered to be primary, at a creatinine concentration was equal to or higher than 300 μmol/L, as well as in the case of needfor maintenance dialysis on the first week after transplantation, the state was classified as the renal graft dysfunction. In the early postoperative period, the number of LIN-HLA-DR+ dendritic cells with the LIN-HLA-DR+CD11c+CD123- and LIN-HLA-DR+CD11c-CD123+ phenotypes in the fluid from the drainage installed to the kidney graft during surgery was determined. Predictive characteristics of the mDC and pDC levels in the drainage fluid were determined to predict renal graft rejection, and diagnostic capability of this indicator were identified. Results. It has been revealed that renal graft rejection is characterized by a significant growth of the total number of dendritic cells in the drainage fluid, mainly due to myeloid ones. Predictive characteristics were determined by the level of myeloid and plasmacytoid dendritic cells in the drainage fluid. The cut-off point of the level of myeloid dendritic cells was determined at the level of 60.32%, and for plasmacytoid dendritic cells it corresponded to 39.68%. Conclusion. With the level of myeloid dendritic cells in the drainage fluid greater or equal 60.32%, and plasmacytoid cells lower or equal 39.68%, renal graft rejection is predicted with a sensitivity of 99% and 93%, respectively, and a specificity of 89% and 91%, respectively. What this paper adds The level of dendritic cells and their subpopulations in the drainage fluid in renal graft recipients has been firstly studied. It has been established that acute renal graft rejection is associated with a high concentration of the total number of dendritic cells in the drainage fluid. More over this increase occurs mainly due to myeloid dendritic cells. The determination of the level of myeloid and plasmacytoid dendritic cells in the drainage fluid can be used as a predictor of renal graft rejection.

2013 ◽  
Vol 40 (7) ◽  
pp. 1200-1211 ◽  
Author(s):  
Floranne C. Ernste ◽  
Cynthia S. Crowson ◽  
Consuelo Lopez de Padilla ◽  
Molly S. Hein ◽  
Ann M. Reed

Objective:To determine the clinical characteristics and subsets of peripheral blood lymphocytes (PBL), which correlate with decreased disease activity in patients with juvenile dermatomyositis (JDM).Methods.Peripheral blood mononuclear cells from 24 patients with JDM were collected at Mayo Clinic Rochester between 2007 and 2011. These were analyzed using fluorescence-activated cell sorting and flow cytometry. Clinical disease activity was determined by visual analog scales (VAS) collected in 2 consecutive visits and correlated with PBL subsets.Results.The change in CD3+CD69+ T cells correlated with the change in global VAS scores. The change in HLA-DR- CD11c+ myeloid dendritic cells also correlated with the change in extramuscular VAS scores. There were trends toward decreased levels of HLA-DR- CD11c+ cells with decreased muscle and global VAS scores, but these did not reach significance. The change in HLA-DR- CD123+ plasmacytoid dendritic cells negatively correlated with the change in muscle VAS scores. Although not statistically significant, decreased levels of CD3-CD16- CD56+ natural killer (NK) cells and HLA-DR- CD86+ myeloid dendritic cells, and increased levels of CD16+CD56- NK cells, correlated with decreased VAS scores.Conclusion.Changes in CD3+CD69+ T cells, HLA-DR- CD11c+ myeloid dendritic cells, and HLA-DR- CD123+ plasmacytoid dendritic cells are associated with improved clinical course in JDM and could be used as markers for disease activity, but findings need to be verified in a larger, independent cohort. Lack of significant differences among most of our PBL subsets suggests that lymphocyte phenotyping may be difficult to definitively correlate with disease activity in JDM.


2006 ◽  
Vol 177 (2) ◽  
pp. 1028-1039 ◽  
Author(s):  
Carlos J. Montoya ◽  
Hyun-Bae Jie ◽  
Lena Al-Harthi ◽  
Candice Mulder ◽  
Pablo J. Patiño ◽  
...  

2021 ◽  
Vol 22 (15) ◽  
pp. 8349
Author(s):  
Giulio Verna ◽  
Marina Liso ◽  
Elisabetta Cavalcanti ◽  
Giusy Bianco ◽  
Veronica Di Sarno ◽  
...  

Dendritic cells (DCs) can be divided by lineage into myeloid dendritic cells (mDCs) and plasmacytoid dendritic cells (pDCs). They both are present in mucosal tissues and regulate the immune response by secreting chemokines and cytokines. Inflammatory bowel diseases (IBDs) are characterized by a leaky intestinal barrier and the consequent translocation of bacterial lipopolysaccharide (LPS) to the basolateral side. This results in DCs activation, but the response of pDCs is still poorly characterized. In the present study, we compared mDCs and pDCs responses to LPS administration. We present a broad panel of DCs secreted factors, including cytokines, chemokines, and growth factors. Our recent studies demonstrated the anti-inflammatory effects of quercetin administration, but to date, there is no evidence about quercetin’s effects on pDCs. The results of the present study demonstrate that pDCs can respond to LPS and that quercetin exposure modulates soluble factors release through the same molecular pathway used by mDCs (Slpi, Hmox1, and AP-1).


Author(s):  
V. A. Sandrikov ◽  
M. M. Kaabak ◽  
E. N. Platova ◽  
V. I. Sadovnikov ◽  
N. N. Babenko ◽  
...  

2011 ◽  
Vol 22 (2) ◽  
pp. 177-188 ◽  
Author(s):  
Maura Rossetti ◽  
Silvia Gregori ◽  
Ehud Hauben ◽  
Brian D. Brown ◽  
Lucia Sergi Sergi ◽  
...  

2019 ◽  
Vol 20 (11) ◽  
pp. 2811 ◽  
Author(s):  
Marta Corsetti ◽  
Gabriella Ruocco ◽  
Serena Ruggieri ◽  
Claudio Gasperini ◽  
Luca Battistini ◽  
...  

Background: Multiple sclerosis (MS) is a chronic inflammatory autoimmune disease of the central nervous system. The cause of multiple sclerosis is unknown but there are several evidences that associate the genetic basis of the disease with environmental causes. An important association between viral infection and development of MS is clearly demonstrated. Viruses have a strong impact on innate immune cells. In particular, myeloid dendritic cells (mDCs) and plasmacytoid dendritic cells (pDCs), are able to respond to viruses and to activate the adaptive immune response. Methods: In this study we mimic viral infection using synthetic single-strand RNA, Resiquimod, and we compared the response of both DC subsets derived from healthy donors and MS patients by characterizing the expression of costimulatory molecules on the DC surface. Results: We found that pDCs from MS patients express higher levels of OX40-L, HLA-DR, and CD86 than healthy donors. Moreover, we found that blood cells from MS patients and healthy donors upon Resiquimod-stimulation are enriched in a subpopulation of pDCs, characterized by a high amount of costimulatory molecules. Conclusion: Overall, these results indicate that activation of pDCs is enhanced in MS, likely due to a latent viral infection, and that costimulatory molecules expressed on pDCs could mediate a protective response against the viral trigger of autoimmunity.


2014 ◽  
Vol 73 (Suppl 2) ◽  
pp. 957.1-957
Author(s):  
S.A. Falaleeva ◽  
V.V. Kurilin ◽  
N.S. Shkaruba ◽  
O.A. Chumasova ◽  
A.E. Sizikov ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document